Alterations of Growth Factors in Autism and Attention-Deficit/Hyperactivity Disorder
- PMID: 28751869
- PMCID: PMC5507945
- DOI: 10.3389/fpsyt.2017.00126
Alterations of Growth Factors in Autism and Attention-Deficit/Hyperactivity Disorder
Abstract
Growth factors (GFs) are cytokines that regulate the neural development. Recent evidence indicates that alterations in the expression level of GFs during embryogenesis are linked to the pathophysiology and clinical manifestations of attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorders (ASD). In this concise review, we summarize the current evidence that supports the role of brain-derived neurotrophic factor, insulin-like growth factor 2, hepatocyte growth factor (HGF), glial-derived neurotrophic factor, nerve growth factor, neurotrophins 3 and 4, and epidermal growth factor in the pathogenesis of ADHD and ASD. We also highlight the potential use of these GFs as clinical markers for diagnosis and prognosis of these neurodevelopmental disorders.
Keywords: attention-deficit/hyperactivity disorder; autism spectrum disorder; biomarker; cerebral cortex; cognitive impairment; cytokines; developmental disorders; growth factors.
Figures
References
-
- Ribases M, Ramos-Quiroga JA, Hervas A, Bosch R, Bielsa A, Gastaminza X, et al. Exploration of 19 serotoninergic candidate genes in adults and children with attention-deficit/hyperactivity disorder identifies association for 5HT2A, DDC and MAOB. Mol Psychiatry (2009) 14(1):71–85. 10.1038/sj.mp.4002100 - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources